PHIO
Phio Pharmaceuticals Corp
NASDAQ: PHIO · HEALTHCARE · BIOTECHNOLOGY
$1.22
+3.39% today
Updated 2026-04-30
Market cap
$13.94M
P/E ratio
—
P/S ratio
48.01x
EPS (TTM)
$-1.45
Dividend yield
—
52W range
$1 – $3
Volume
0.3M
Phio Pharmaceuticals Corp (PHIO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-9.99M | $-5.06M | $-6.31M | $-7.76M | $-7.32M | $-7.76M | $-9.51M | $-7.52M | $-8.64M | $-8.80M | $-11.86M | $-12.13M | $-10.75M | $-7.11M | $-7.98M |
| Capital expenditures | $59000.00 | $15000.00 | $78000.00 | $95000.00 | $57000.00 | $4000.00 | $203000.00 | $5000.00 | $72000.00 | $19000.00 | $51000.00 | $121000.00 | $5000.00 | $1000.00 | $12000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $2.11M | $968000.00 | $1.98M | $1.85M | $1.53M | $756000.00 | $314000.00 | $282000.00 | $300000.00 | $136000.00 | $480000.00 | $414000.00 | $303000.00 | $147000.00 | $481000.00 |
| Free cash flow | $-10.05M | $-5.08M | $-6.39M | $-7.85M | $-7.37M | $-7.76M | $-9.72M | $-7.53M | $-8.72M | $-8.82M | $-11.91M | $-12.25M | $-10.75M | $-7.11M | $-7.99M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $12000.00 | $4.13M | $209000.00 | — | — | — | $1000.00 | $4.09M | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $6.26M | $-2.89M | $-3.38M | $7.79M | $-9.32M | $11.30M | $-7.95M | $7.31M | — | — | — | — | — |